Similar articles for PMID: 31490318

Year	Number of Results
2001	1
2002	2
2003	2
2004	2
2005	2
2007	4
2009	4
2010	4
2011	6
2012	3
2013	7
2014	10
2015	7
2016	12
2017	17
2018	17
2019	20
2020	8
2021	2

1

Allogenic hematopoietic stem cell transplantation in sickle cell disease.

Galal A, Asslan M. Galal A, et al. Curr Opin Hematol. 2019 Nov;26(6):399-405. doi: 10.1097/MOH.0000000000000545. Curr Opin Hematol. 2019. PMID: 31490318 Review.

2

Alternative donor: αß/CD19 T-cell-depleted haploidentical hematopoietic stem cell transplantation for sickle cell disease.

Foell J, Kleinschmidt K, Jakob M, Troeger A, Corbacioglu S. Foell J, et al. Hematol Oncol Stem Cell Ther. 2020 Jun;13(2):98-105. doi: 10.1016/j.hemonc.2019.12.006. Epub 2020 Mar 12. Hematol Oncol Stem Cell Ther. 2020. PMID: 32202248 Free article. Review.

3

Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.

Wiebking V, Hütker S, Schmid I, Immler S, Feuchtinger T, Albert MH. Wiebking V, et al. Ann Hematol. 2017 Aug;96(8):1373-1377. doi: 10.1007/s00277-017-3030-x. Epub 2017 Jun 1. Ann Hematol. 2017. PMID: 28573314

4

Curative therapies: Allogeneic hematopoietic cell transplantation from matched related donors using myeloablative, reduced intensity, and nonmyeloablative conditioning in sickle cell disease.

Guilcher GMT, Truong TH, Saraf SL, Joseph JJ, Rondelli D, Hsieh MM. Guilcher GMT, et al. Semin Hematol. 2018 Apr;55(2):87-93. doi: 10.1053/j.seminhematol.2018.04.011. Epub 2018 Apr 25. Semin Hematol. 2018. PMID: 29958564 Free PMC article. Review.

5

Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in children with sickle cell disease.

Strocchio L, Zecca M, Comoli P, Mina T, Giorgiani G, Giraldi E, Vinti L, Merli P, Regazzi M, Locatelli F. Strocchio L, et al. Br J Haematol. 2015 Jun;169(5):726-36. doi: 10.1111/bjh.13352. Epub 2015 Mar 27. Br J Haematol. 2015. PMID: 25818248

6

Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?

Leonard A, Tisdale J, Abraham A. Leonard A, et al. Br J Haematol. 2020 May;189(3):408-423. doi: 10.1111/bjh.16437. Epub 2020 Feb 7. Br J Haematol. 2020. PMID: 32034776 Review.

7

Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.

Soni S, Gross TG, Rangarajan H, Baker KS, Sturm M, Rhodes M. Soni S, et al. Pediatr Blood Cancer. 2014 Sep;61(9):1685-9. doi: 10.1002/pbc.25059. Epub 2014 Apr 17. Pediatr Blood Cancer. 2014. PMID: 24740582

8

Hematopoietic stem cell transplantation for sickle cell disease: Progress and challenges.

Hulbert ML, Shenoy S. Hulbert ML, et al. Pediatr Blood Cancer. 2018 Sep;65(9):e27263. doi: 10.1002/pbc.27263. Epub 2018 May 24. Pediatr Blood Cancer. 2018. PMID: 29797658 Review.

9

Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.

Hsieh MM, Fitzhugh CD, Weitzel RP, Link ME, Coles WA, Zhao X, Rodgers GP, Powell JD, Tisdale JF. Hsieh MM, et al. JAMA. 2014 Jul 2;312(1):48-56. doi: 10.1001/jama.2014.7192. JAMA. 2014. PMID: 25058217 Free PMC article. Clinical Trial.

10

Stable renal function in children and adolescents with sickle cell disease after nonmyeloablative hematopoietic stem cell transplantation.

Pedersen SJV, Monagel DA, Mammen C, Lewis VA, Guilcher GMT, Bruce AA. Pedersen SJV, et al. Pediatr Blood Cancer. 2020 Sep;67(9):e28568. doi: 10.1002/pbc.28568. Epub 2020 Jul 16. Pediatr Blood Cancer. 2020. PMID: 32672896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed